NEW YORK, March 11, 2014 (GLOBE NEWSWIRE) -- Clifford Chance is advising Summit Health, a leading provider of on-site prevention and wellness programs primarily for employers, on its sale to Quest Diagnostics, the world's leading provider of diagnostic information services. The deal is subject to regulatory approvals and other customary closing conditions, and is expected to close in the first half of 2014. Terms of the transaction were not disclosed.
The Clifford Chance team advising Summit Heath is being led by New York-based M&A partner Benjamin Sibbett, and includes partners Howard Adler (ERISA), Don Carden (Tax) and Jeff Butler (Litigation), counsel Vicky Manthas (Real Estate), Daryl Fairbairn (Intellectual Property) and Tim Cornell (Antitrust), and associates Paul Wellington (M&A), Michelle Pham (M&A), Carla Gorniak (ERISA) and Eric Naftel (Tax).
Notes to Editors:
Clifford Chance is one of the world's leading law firms, helping clients achieve their goals by combining the highest global standards with local expertise. The Firm has unrivalled scale and depth of legal resources across the five major regions of the Americas, Africa, Asia Pacific, Europe and the Middle East, and focuses on the core areas of commercial activity: capital markets; corporate and M&A; finance and banking; real estate; tax, pensions and employment; litigation and dispute resolution. Clifford Chance has 36 offices in 26 countries with some 3,400 legal advisers.
Clifford Chance was ranked 'band one' in more cross-border tables than any other firm in the Chambers Global 2013 Directory. This independent analysis focuses on firms' legal ability, professional conduct, client service, and commercial awareness, and these rankings provide outstanding recognition for the Firm's breadth of expertise and consistency of quality across global markets.